Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum Disorders

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

196

Participants

Timeline

Start Date

June 16, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

September 14, 2018

Conditions

Sleep DisordersAutism Spectrum Disorder

Interventions

DRUG

NPC-15 Granules Lower Dose

NPC-15 granule which contains 1mg melatonin

DRUG

NPC-15 Granules Higher Dose

Melatonin granule which contains 4 mg melatonin

DRUG

NPC-15 Placebo Granule

Melatonin placebo granule which does not contains melatonin.